Consuming sugar-sweetened drinks, but not artificially sweetened beverages, may be associated with higher rates of liver cancer and death from liver disease, new data show.
A new update to the American Diabetes Association s Standards of Care advises use of the fibrosis-4 (FIB-4) index for screening and use of GLP-1 agonists or pioglitazone for treatment.
The 52-week results of the phase 3 MAESTRO-NASH trial show promise for resmetirom. One expert called the trial results real game-changer in the field of fatty liver disease. ยง
People with signs of the most advanced liver disease should see a hepatologist, experts say, while primary care clinicians can effectively treat lower-risk cases.